Disrupted sensory gating in pathological gambling

Biological Psychiatry

Volumn 54, Issue 4, 2003, Pages 474-484

  Stojanov, Wendy ^a,b   Karayanidis, Frini ^a,b   Johnston, Patrick ^a,b   Bailey, Andrew ^b   Carr, Vaughan ^a,b   Schall, Ulrich ^a,b  

^a HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Acoustic startle eye blink reflex; Dopamine; P300; Pathological gambling; Prepulse inhibition; Sensory motor gating

Indexed keywords

ADULT; ARTICLE; AUDITORY SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DOPAMINE BRAIN LEVEL; EVENT RELATED POTENTIAL; EYELID REFLEX; FEMALE; HUMAN; MALE; MEDICAL ASSESSMENT; MEDICAL RECORD; PATHOLOGICAL GAMBLING; PREPULSE INHIBITION; PRIORITY JOURNAL; SENSORY SYSTEM;

EID: 0142042982     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(02)01745-6     Document Type: Article

References (61)

1. Abduljawad K.A., Langley R.W., Bradshaw C.M., Szabadi E. Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man. J Psychopharmacol. 12:1998;239-245.
2. Diagnostic and Statistical Manual of Mental Disorders. 4th ed:1994;American Psychiatric Press, Washington, DC.
3. Anderson G., Brown R.I. Real and laboratory gambling, sensation-seeking and arousal. Br J Psychol. 75:1984;401-410.
4. Bender S., Schall U., Wolstein J., Grzella I., Zerbin D., Oades R.D. A topographic event-related potential follow-up study on 'prepulse inhibition' in first and second episode patients with schizophrenia. Psychiatry Res Neuroimaging. 90:1999;41-53.
5. Bergh C., Eklund T., Södersten P., Nordin C. Altered dopamine function in pathological gambling. Psychol Med. 27:1997;473-475.
6. Blanco C., Orensanz-Muñoz L., Blanco-Jerez C., Sáiz-Ruiz J. Pathological gambling and platelet MAO activity A psychobiological study . Am J Psychiatry. 153:1996;119-121.
7. Blum K., Braverman E.R., Wu S., Cull J.G., Chen T.J.H., Gill J., et al. Association of polymorphisms of dopamine D2 receptor (DRD2), and dopamine transporter (DAT1) genes with schizoid/avoidant behaviours (SAB). Mol Psychiatry. 2:1997;239-246.
8. Blum K., Sheridan P.J., Wood R.C., Braverman E.R., Chen T.J., Comings D.E. Dopamine D2 receptor gene variants Association and linkage studies in impulsive-addictive-compulsive behaviour . Pharmacogenetics. 5:1995;121-141.
9. Blum K., Sheridan P.J., Wood R.C., Braverman E.R., Chen T.J.H., Cull J.G., et al. The D2 dopamine receptor gene as a determinant of reward deficiency syndrome. J R Soc Med. 89:1996;396-400.
10. Braff D., Stone C., Callaway E., Geyer M., Glick I., Bali L. Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology. 15:1978;339-343.
11. Braff D.L., Grillon C., Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry. 49:1992;206-215.
12. Bubser M., Koch M. Prepulse inhibition of the acoustic startle response of rats is reduced by 6-hydroxydopamine lesions of the medial prefrontal cortex. Psychopharmacology. 113:1994;487-492.
13. Cadenhead K.S., Swerdlow N.R., Shafer K.M., Diaz M., Braff D.L. Modulation of the startle response and startle laterality in relatives of schizophrenia patients and schizotypal personality disordered subjects Evidence of inhibitory deficits . Am J Psychiatry. 157:2000;1660-1668.
14. Carrasco J.L., Sáiz-Ruiz J., Hollander E., César J., López-Ibor J.J. Low platelet monoamine oxidase activity in pathological gambling. Acta Psychiatr Scand. 90:1994;427-431.
15. Castellanos F.X., Fine E.J., Kaysen D., Marsh W.L., Rapoport J.L., Hallett M. Sensorimotor gating in boys with Tourette's syndrome and ADHD Preliminary results . Biol Psychiatry. 39:1996;33-41.
16. Comings D.E., Gade R., Wu S., Chiu C., Dietz G., Muhleman D., et al. Studies of the potential role of the dopamine D1 receptor gene in addictive behaviours. Mol Psychiatry. 2:1997;44-56.
17. Comings D.E., Gonzalez N., Wu S., Gade R., Muhleman D., Saucier G., et al. Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviours Tourette syndrome, ADHD, pathological gambling, and substance abuse . Am J Med Genet. 88:1999;358-368.
18. Comings D.E., Rosenthal R.J., Lesieur H.R., Rugle L.J., Muhleman D., Chiu C., et al. A study of the dopamine D2 receptor gene in pathological gambling. Pharmacogenetics. 6:1996;223-234.
19. Dawson M.E., Hazlett E.A., Filion D.L., Nuechterlein K.H., Schell A.M. Attention and schizophrenia Impaired modulation of the startle reflex . J Abnorm Psychol. 102:1993;633-641.
20. Ellenbroek B.A., Budde S., Cools A.R. Prepulse inhibition and latent inhibition The role of dopamine in the medial prefrontal cortex . Neuroscience. 75:1996;535-542.
21. First MB, Gibbon M, Williams JBW, Spitzer RL, MHS Systems Inc (1996): SCID Screening Patient Questionnaire (SCID-Screen-PQ) Computer Program. Toronto, Canada: Multi-Health Systems Inc. & American Psychiatric Press Inc.
22. Ford J.M., Roth W.T., Kopell B.S. Attention effects on auditory evoked potentials to infrequent events. Biol Psychology. 4:1976;65-77.
23. Graham F.K. The more or less startling effects of weak prestimulation. Psychophysiology. 12:1975;238-248.
24. Grillon C., Ameli R., Charney D.S., Krystal J., Braff D. Startle gating deficits occur across prepulse intensities in schizophrenic patients. Biol Psychiatry. 32:1992;939-943.
25. Heidbreder C.A., Weiss I.C., Domeney A.M., Pryce C., Homberg J., Hedou G., et al. Behavioural, neurochemical and endocrinological characterisation of the early social isolation syndrome. Neuroscience. 100:2000;749-768.
26. Hollander E., DeCaria C.M., Mari E., Wong C.M., Mosovich S., Grossman R., et al. Short-term single-blind fluvoxamine treatment of pathological gambling. Am J Psychiatry. 155:1998;1781-1783.
27. Hollander E., Frenkel M., DeCaria C., Trungold S., Stein D.J. Treatment of pathological gambling with clomipramine (letter). Am J Psychiatry. 149:1992;710-711.
28. Hutchison K.E., Swift R. Effect of d-amphetamine on prepulse inhibition of the startle reflex in humans. Psychopharmacology. 143:1999;394-400.
29. Jasper H.H. The ten twenty electrode system of the international federation. Electroencephalogr Clin Neurophysiol. 10:1958;371-375.
30. Kim S.W. Opioid antagonists in the treatment of impulse-control disorders. J Clin Psychiatry. 59:1998;159-164.
31. Kim S.W., Grant J.E. The psychopharmacology of pathological gambling. Semin Clin Neuropsychiatry. 6:2001;184-194.
32. Kröner S., Schall U., Ward P.B., Sticht G., Banger M., Haffner H.T., et al. Effects of prepulses and d-amphetamine on performance and event-related potential measures on an auditory discrimination task. Psychopharmacology. 145:1999;123-132.
33. Mansbach R.S., Geyer M.A., Braff D.L. Dopaminergic stimulation disrupts sensorimotor gating in the rat. Psychopharmacology. 94:1988;507-514.
34. Marinelli M., Barrot M., Simon H., Oberlander C., Dekeyne A., Le Moal M., et al. Pharmacological stimuli decreasing nucleus accumbens dopamine can act as positive reinforcer but have a low addictive potential. Eur J Neurosci. 10:1998;3269-3275.
35. Martel P., Fantino M. Mesolimbic dopaminergic system activity as a function of food reward A microdialysis study . Pharmacol Biochem Behav. 53:1996;221-226.
36. Moreno I., Saiz-Ruiz J., López-Ibor J.J. Serotonin and gambling dependence. Human Psychopharmacology. 6:(suppl):1991;S9-S12.
37. Navarro J.F., Pedraza C. Pathological gambling Biological aspects . Psicologia Conductual. 6:1998;157-164.
38. Nordin C., Eklundh T. Altered CSF 5HIAA disposition in pathological male gamblers. CNS Spectrums. 4:1999;25-33.
39. Ornitz E.M., Russell A.T., Hanna G.L., Gabikian P., Gehricke J., Song D., et al. Prepulse inhibition of startle and the neurobiology of primary nocturnal enuresis. Biol Psychiatry. 45:1999;1455-1466.
40. Perez de Castro I., Ibanez A., Torres P., Saiz-Ruiz J., Fernandez-Piqueras J. Genetic association study between pathological gambling and a functional DNA polymorphism at the D4 receptor gene. Pharmacogenetics. 7:1997;345-348.
41. Perris C., Jacobsson L., Von Knorring L., Oreland L., Perris H., Ross S.B. Enzymes related to biogenic amine metabolism and personality characteristics in depressed patients. Acta Psychiatr Scand. 61:1980;477-484.
42. Potenza M.N., Kosten T.R., Rounsaville B.J. Pathological gambling. JAMA. 281:2001;141-144.
43. Ralph R.J., Paulus M.P., Fumagalli F., Caron M.G., Geyer M.A. Prepulse inhibition deficits and perseverative motor pattern in dopamine transporter knock-out mice Differential effect of D1 and D2 receptor antagonists . J Neurosci. 21:2001;305-313.
44. Roy A., Adinoff B., Roehrich L., Lamparski D., Custer R., Lorenz V., et al. Pathological gambling A psychobiological study . Arch Gen Psychiatry. 45:1988;369-373.
45. Schall U., Catts S.V., Karayanidis F., Ward P.B. Auditory event-related potential indices of fronto-temporal information processing in schizophrenia syndromes Valid outcome prediction of clozapine therapy in a three-year follow-up . Int J Neuropsychopharmacol. 2:1999;83-93.
46. Schall U., Schön A., Zerbin D., Bender S., Eggers C., Oades R.D. A left temporal lobe impairment of auditory information processing in schizophrenia An event-related potential study . Neurosci Lett. 229:1997;25-28.
47. Schall U., Schön A., Zerbin D., Eggers C., Oades R.D. Event-related potentials during an auditory discrimination with prepulse inhibition in patients with schizophrenia, obsessive-compulsive disorder and healthy subjects. Int J Neurosci. 84:1996;15-33.
48. Schall U., Ward P.B. 'Prepulse inhibition' facilitates a liberal response bias in an auditory discrimination task. Neuroreport. 7:1996;652-656.
49. Schicatano E.J., Peshori K.R., Gopalaswamy R., Sahay E., Evinger C. Reflex excitability regulates prepulse inhibition. J Neurosci. 20:2000;4240-4247.
50. Schwarzkopf S.B., Bruno J.P., Mitra T., Ison J.R. Effects of haloperidol and SCH 2330 on acoustic startle in animals depleted of dopamine as neonates Implications for neuropsychiatric syndromes . Psychopharmacology. 123:1996;258-266.
51. Seedat S., Kesler S., Niehaus D.J., Stein D.J. Pathological gambling behaviour Emergence secondary to treatment of Parkinson's disease with dopaminergic agents . Depress Anxiety. 11:2000;185-186.
52. Semlitsch H.V., Anderer P., Schuster P., Presslich O. A solution for reliable and valid reduction of ocular artifacts, applied to the P300 ERP. Psychophysiology. 23:1986;695-703.
53. Swerdlow N.R., Benbow C.H., Zisook S., Geyer M.A., Braff D.L. A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biol Psychiatry. 33:1993;298-301.
54. Swerdlow N.R., Braff D.L., Taaid N., Geyer M.A. Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients. Arch Gen Psychiatry. 51:1994;139-154.
55. Swerdlow N.R., Geyer M.A. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull. 24:1998;285-302.
56. Swerdlow N.R., Hartman P.L., Auerbach P.P. Changes in sensorimotor inhibition across the menstrual cycle Implications for neuropsychiatric disorders . Biol Psychiatry. 41:1997;452-460.
57. Swerdlow N.R., Lipska B.K., Weinberger D.R., Braff D.L., Jaskiw G.E., Geyer M.A. Increased sensitivity to the sensorimotor gating-disruptive effects of apomorphine after lesions of medial prefrontal cortex or ventral hippocampus in adult rats. Psychopharmacology. 122:1995;27-34.
58. Swerdlow N.R., Paulsen J., Braff D.L., Butters N., Geyer M.A., Swenson M.R. Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. J Neurol Neurosurg Psychiatry. 58:1995;192-200.
59. Swerdlow N.R., Platten A., Kim Y.K., Gaudet I., Shoemaker J., Pitcher L., et al. Sensitivity to the dopaminergic regulation of prepulse inhibition in rats Evidence for genetic, but not environmental determinants . Pharmacol Biochem Behav. 70:2001;219-226.
60. Swerdlow NR, Wasserman L, Talledo JA, Casas R, Bruins P, Stephany NL (in press): Prestimulus modification of the startle reflex: Relationship to personality and physiological markers of dopamine function. Biol Psychol.
61. Virkkunen M., Nuutila A., Goodwin F.K., Linnoila M. Cerebrospinal fluid monoamine metabolite levels in male arsonists. Arch Gen Psychiatry. 44:1987;241-247.